Literature DB >> 30201609

mTORC2 modulates the amplitude and duration of GFAT1 Ser-243 phosphorylation to maintain flux through the hexosamine pathway during starvation.

Joseph G Moloughney1, Nicole M Vega-Cotto1, Sharon Liu1, Chadni Patel1, Peter K Kim1, Chang-Chih Wu1, Danielle Albaciete1, Cedric Magaway1, Austin Chang1, Swati Rajput1, Xiaoyang Su2, Guy Werlen1, Estela Jacinto3.   

Abstract

The mechanistic target of rapamycin (mTOR) controls metabolic pathways in response to nutrients. Recently, we have shown that mTOR complex 2 (mTORC2) modulates the hexosamine biosynthetic pathway (HBP) by promoting the expression of the key enzyme of the HBP, glutamine:fructose-6-phosphate aminotransferase 1 (GFAT1). Here, we found that GFAT1 Ser-243 phosphorylation is also modulated in an mTORC2-dependent manner. In response to glutamine limitation, active mTORC2 prolongs the duration of Ser-243 phosphorylation, albeit at lower amplitude. Blocking glycolysis using 2-deoxyglucose robustly enhances Ser-243 phosphorylation, correlating with heightened mTORC2 activation, increased AMPK activity, and O-GlcNAcylation. However, when 2-deoxyglucose is combined with glutamine deprivation, GFAT1 Ser-243 phosphorylation and mTORC2 activation remain elevated, whereas AMPK activation and O-GlcNAcylation diminish. Phosphorylation at Ser-243 promotes GFAT1 expression and production of GFAT1-generated metabolites including ample production of the HBP end-product, UDP-GlcNAc, despite nutrient starvation. Hence, we propose that the mTORC2-mediated increase in GFAT1 Ser-243 phosphorylation promotes flux through the HBP to maintain production of UDP-GlcNAc when nutrients are limiting. Our findings provide insights on how the HBP is reprogrammed via mTORC2 in nutrient-addicted cancer cells.
© 2018 Moloughney et al.

Entities:  

Keywords:  Akt PKB; cell metabolism; glutamine; glutaminolysis; hexosamine biosynthesis; hexosamine biosynthetic pathway; mTOR; mTOR complex (mTORC); metabolism; nutrients; protein phosphorylation

Mesh:

Substances:

Year:  2018        PMID: 30201609      PMCID: PMC6200946          DOI: 10.1074/jbc.RA118.003991

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  45 in total

1.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

2.  mTOR Signaling in Growth, Metabolism, and Disease.

Authors:  Robert A Saxton; David M Sabatini
Journal:  Cell       Date:  2017-04-06       Impact factor: 41.582

Review 3.  Understanding the Intersections between Metabolism and Cancer Biology.

Authors:  Matthew G Vander Heiden; Ralph J DeBerardinis
Journal:  Cell       Date:  2017-02-09       Impact factor: 41.582

4.  PtdIns(3,4,5)P3-Dependent Activation of the mTORC2 Kinase Complex.

Authors:  Pengda Liu; Wenjian Gan; Y Rebecca Chin; Kohei Ogura; Jianping Guo; Jinfang Zhang; Bin Wang; John Blenis; Lewis C Cantley; Alex Toker; Bing Su; Wenyi Wei
Journal:  Cancer Discov       Date:  2015-08-20       Impact factor: 39.397

5.  mTOR complex 2 regulates proper turnover of insulin receptor substrate-1 via the ubiquitin ligase subunit Fbw8.

Authors:  Sung Jin Kim; Michael A DeStefano; Won Jun Oh; Chang-chih Wu; Nicole M Vega-Cotto; Monica Finlan; Dou Liu; Bing Su; Estela Jacinto
Journal:  Mol Cell       Date:  2012-11-08       Impact factor: 17.970

6.  T cell-specific loss of Pten leads to defects in central and peripheral tolerance.

Authors:  A Suzuki; M T Yamaguchi; T Ohteki; T Sasaki; T Kaisho; Y Kimura; R Yoshida; A Wakeham; T Higuchi; M Fukumoto; T Tsubata; P S Ohashi; S Koyasu; J M Penninger; T Nakano; T W Mak
Journal:  Immunity       Date:  2001-05       Impact factor: 31.745

7.  Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signalling.

Authors:  Tsuneo Ikenoue; Ken Inoki; Qian Yang; Xiaoming Zhou; Kun-Liang Guan
Journal:  EMBO J       Date:  2008-06-19       Impact factor: 11.598

Review 8.  Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer.

Authors:  R J DeBerardinis; T Cheng
Journal:  Oncogene       Date:  2009-11-02       Impact factor: 9.867

Review 9.  The Emerging Hallmarks of Cancer Metabolism.

Authors:  Natalya N Pavlova; Craig B Thompson
Journal:  Cell Metab       Date:  2016-01-12       Impact factor: 27.287

10.  Loss of GFAT1 promotes epithelial-to-mesenchymal transition and predicts unfavorable prognosis in gastric cancer.

Authors:  Fangfang Duan; Dongwei Jia; Junjie Zhao; Weicheng Wu; Lingqiang Min; Shushu Song; Hao Wu; Lan Wang; Hongshan Wang; Yuanyuan Ruan; Jianxin Gu
Journal:  Oncotarget       Date:  2016-06-21
View more
  16 in total

Review 1.  Mechanisms of coordinating hyaluronan and glycosaminoglycan production by nucleotide sugars.

Authors:  Brenna M Zimmer; Joseph J Barycki; Melanie A Simpson
Journal:  Am J Physiol Cell Physiol       Date:  2022-04-20       Impact factor: 5.282

Review 2.  Regulation of cardiac O-GlcNAcylation: More than just nutrient availability.

Authors:  Helen E Collins; John C Chatham
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-01-31       Impact factor: 5.187

3.  KPT-9274, an Inhibitor of PAK4 and NAMPT, Leads to Downregulation of mTORC2 in Triple Negative Breast Cancer Cells.

Authors:  Emma Cordover; Janet Wei; Chadni Patel; Naing Lin Shan; John Gionco; Davit Sargsyan; Renyi Wu; Li Cai; Ah-Ng Kong; Estela Jacinto; Audrey Minden
Journal:  Chem Res Toxicol       Date:  2020-01-09       Impact factor: 3.973

Review 4.  Regulation and metabolic functions of mTORC1 and mTORC2.

Authors:  Angelia Szwed; Eugene Kim; Estela Jacinto
Journal:  Physiol Rev       Date:  2021-02-18       Impact factor: 46.500

Review 5.  Fueling the fire: emerging role of the hexosamine biosynthetic pathway in cancer.

Authors:  Neha M Akella; Lorela Ciraku; Mauricio J Reginato
Journal:  BMC Biol       Date:  2019-07-04       Impact factor: 7.431

Review 6.  Targeting mTOR for cancer therapy.

Authors:  Hui Hua; Qingbin Kong; Hongying Zhang; Jiao Wang; Ting Luo; Yangfu Jiang
Journal:  J Hematol Oncol       Date:  2019-07-05       Impact factor: 17.388

7.  CaMeRe: A Novel Tool for Inference of Cancer Metabolic Reprogramming.

Authors:  Haoyang Li; Juexiao Zhou; Huiyan Sun; Zhaowen Qiu; Xin Gao; Ying Xu
Journal:  Front Oncol       Date:  2020-02-25       Impact factor: 6.244

Review 8.  Targeting mTOR and Metabolism in Cancer: Lessons and Innovations.

Authors:  Cedric Magaway; Eugene Kim; Estela Jacinto
Journal:  Cells       Date:  2019-12-06       Impact factor: 6.600

9.  mTORC2 Is Involved in the Induction of RSK Phosphorylation by Serum or Nutrient Starvation.

Authors:  Po-Chien Chou; Swati Rajput; Xiaoyun Zhao; Chadni Patel; Danielle Albaciete; Won Jun Oh; Heineken Queen Daguplo; Nikhil Patel; Bing Su; Guy Werlen; Estela Jacinto
Journal:  Cells       Date:  2020-06-27       Impact factor: 6.600

10.  GFAT1/HBP/O-GlcNAcylation Axis Regulates β-Catenin Activity to Promote Pancreatic Cancer Aggressiveness.

Authors:  Chunzeng Jia; Hengchao Li; Deliang Fu; Yu Lan
Journal:  Biomed Res Int       Date:  2020-02-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.